scholarly journals Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma

2014 ◽  
pp. 79 ◽  
Author(s):  
Robert Chen ◽  
Tanya Siddiqi ◽  
Sandra Thomas
Keyword(s):  
Hodgkin Lymphoma ◽  
Brentuximab Vedotin ◽  
Refractory Hodgkin Lymphoma

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents

2016 ◽  
Vol 16 (3) ◽  
pp. 347-364 ◽  
Author(s):  
Massimo Martino ◽  
Moreno Festuccia ◽  
Roberta Fedele ◽  
Giuseppe Console ◽  
Michele Cimminiello ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Brentuximab Vedotin ◽  
Salvage Treatment ◽  
Refractory Hodgkin Lymphoma

scholarly journals Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma

2015 ◽  
Vol 22 (1) ◽  
pp. 188-192 ◽  
Author(s):  
Marie Fizesan ◽  
Christopher Boin ◽  
Olivier Aujoulat ◽  
Georges Newinger ◽  
Dana Ghergus ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Brentuximab Vedotin ◽  
Antibody Drug Conjugate ◽  
Drug Conjugate ◽  
Refractory Hodgkin Lymphoma ◽  
Antibody Drug

Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients

2021 ◽  
pp. 1-9
Author(s):  
Bahar Uncu Ulu ◽  
Mehmet Sinan Dal ◽  
İpek Yönal Hindilerden ◽  
Olga Meltem Akay ◽  
Özgür Mehtap ◽  
...  
Keyword(s):  
Hodgkin Lymphoma ◽  
Salvage Therapy ◽  
Brentuximab Vedotin ◽  
Refractory Hodgkin Lymphoma

scholarly journals Brentuximab Vedotin in Transplant‐Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

2012 ◽  
Vol 17 (8) ◽  
pp. 1073-1080 ◽  
Author(s):  
Andres Forero‐Torres ◽  
Michelle Fanale ◽  
Ranjana Advani ◽  
Nancy L. Bartlett ◽  
Joseph D. Rosenblatt ◽  
...  
Keyword(s):  
Phase I ◽  
Hodgkin Lymphoma ◽  
Brentuximab Vedotin ◽  
Two Phase ◽  
Phase I Studies ◽  
Refractory Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document